Showing results (651-660 of 737) with videos related to

Sort By:
Pageof 74
Elife|February 21, 2023
Orai3 and Orai1 mediate CRAC channel function and metabolic reprogramming in B cellsScott M Emrich, Ryan E Yoast, Xuexin Zhang, et al.
Zhonghua Yi Xue Za Zhi|January 26, 2025
[Predictive model for ejection fraction improvement at one year in patients with acute ST-segment elevation myocardial infarction complicated with heart failure with reduced ejection fraction]Z Y Tao, H Zhao, Z Wang, et al.
The Review of Scientific Instruments|July 10, 2021
Toroidal soft x-ray array on the EXL-50 spherical tokamakX L Huang, Y P Zhang, Y B Zhu, et al.
Oncogene|July 6, 2018
Correction: eEF-2 kinase is a critical regulator of Warbrug effect through controlling PP2A-A synthesisY Cheng, X Ren, Y Yuan, et al.
Oncogene|May 17, 2016
eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesisY Cheng, X Ren, Y Yuan, et al.
Oncogene|March 26, 2014
Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapyL Xiao, Z-Y Hu, X Dong, et al.
Clinical Pharmacology and Therapeutics|December 25, 2009
Pharmacokinetics of 23-epi-26-deoxyactein in women after oral administration of a standardized extract of black cohoshR B van Breemen, W Liang, S Banuvar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trialY Tao, J Biau, X S Sun, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|January 11, 2024
[A multi-dimensional analysis of pollen broadcasting concerns in Chinese population: a large-scale multi-center cross-sectional survey]C Y Xu, Y S Zhang, N Luan, et al.
Frontiers in Oncology|October 22, 2025
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinomaJ-P Machiels, Y Tao, L Licitra, et al.
Pageof 74